Skip to content

A study of Erandmuladi netra pindi treatment with haridrakhand (by mouth) in simple allergic conjunctivitis disease.

A controlled clinical study to evaluate the add-on effect of Erandmuladi netra pindi with Haridra khand orally in simple allergic conjunctivitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047506
Enrollment
60
Registered
2022-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

PDEAs college of ayurved and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients from age group of 18 to 50 years irrespective of Gender, Religion, occupation. 2. Patients having atleast 3 signs and symptoms of simple Allergic conjunctivitis as below : 1. Itching 2. Watery discharge 3. Pricking sensation 4. Edema of eyelids 5. Hyperemia 6. Chemosis

Exclusion criteria

Exclusion criteria: 1. Known case of congenital anomalies of eye, ocular pathology, conjunctivitis with corneal involvement, infective conjunctivitis. 2. Patient with the history of recent ophthalmic surgeries.

Design outcomes

Primary

MeasureTime frame
to identify the difference of treatment for management of simple allergic conjunctivitis.to compare the effectivenss of treatment over period of time.to compare the efficacy of haridrakhand with and without erandmuladi pindi in simple allergic conjunctivitis.Timepoint: 15 days treatment with two followups on 7th and 15th day. symptoms of simple allergic conjunctivitis seen reduced in 1 week

Secondary

MeasureTime frame
1.To assess the efficacy of erandmuladi netra pindi 7 days with haridrakhand orally for 15 days with obsevation of reduced clinical features. 2.To assess the effect of erandmuladi netra pindi 7 days without haridrakhand orally with observation of reduced clinical features. to observe the adverse effect of drug if any.Timepoint: 15 days treatment with two followups on 7th and 15th day.

Countries

India

Contacts

Public ContactDr Snehal Maske

PDEAs college of ayurved and research centre

drvirkarchandana@gmail.com9822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026